Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced non-small-cell lung cancer (NSCLC) leading to substantial improvement in survival time and quality of life. Nevertheless, the clinical benefit of treatment is still limited to a minority of patients, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantano, Francesco, Zalfa, Francesca, Iuliani, Michele, Simonetti, Sonia, Manca, Paolo, Napolitano, Andrea, Tiberi, Simone, Russano, Marco, Citarella, Fabrizio, Foderaro, Simone, Vulpis, Elisabetta, Zingoni, Alessandra, Masuelli, Laura, Bei, Roberto, Ribelli, Giulia, Del Re, Marzia, Danesi, Romano, Vincenzi, Bruno, Perrone, Giuseppe, Tonini, Giuseppe, Santini, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139420/
https://www.ncbi.nlm.nih.gov/pubmed/35626040
http://dx.doi.org/10.3390/cancers14102435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139420/
https://www.ncbi.nlm.nih.gov/pubmed/35626040
http://dx.doi.org/10.3390/cancers14102435

Ejemplares similares